EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence

Erin L Martin iD, Nathaniel L Baker iD, Cristina Sempio, Uwe Christians, Jost Klawitter, Aimee L McRae-Clark

Addiction Biology · 2023

DOI: 10.1111/adb.13337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction Biology, 2023. Verfasst von Erin L Martin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina, USA. Hauptthemen laut MEDLINE: Cannabis, Marijuana Abuse, Substance-Related Disorders, Substance Withdrawal Syndrome. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, NCATS NIH HHS, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabis use disorder (CUD) presents differently in men and women, particularly in symptoms of cannabis withdrawal. Novel pharmacotherapeutic interventions for CUD, such as those that target the endocannabinoid (eCB) system, must be developed in a manner consistent with these sex differences. The present pilot study sought to prospectively assess sex differences in cannabis withdrawal in a small sample of adults with moderate‐to‐severe CUD and to determine if withdrawal was associated with peripheral eCB and eCB congener tone. Men and women ( n = 5/sex) completed 2 weeks of study participation separated by 1 month; in the latter week, participants abstained from cannabis use. Each week, participants attended in‐person laboratory visits during which blood was drawn repeatedly to assess plasma eCB and eCB congener tone. Participants also completed multiple daily ambulatory assessments to assess cannabis use and withdrawal symptoms. As anticipated, women reported a greater increase in withdrawal symptoms during the abstinent week [Δ = 9.4 (SE = 1.1); p < 0.001] than men [Δ = 1.2 (SE = 1.2); p = 0.35]. Sex differences in levels of the eCB N ‐arachidonoylethanolamide (AEA), as well as the eCB congeners stearoylethanolamide (SEA) and linoleylethanolamide (LEA), were evident during abstinence at the morning time point only ( p 's < 0.05). LEA was associated with withdrawal symptom expression in both sexes [β = 0.16 (SE = 0.09)] and palmitoylethanolamide (PEA) [β = 0.22 (SE = 0.13)] and 2‐arachidonoylglycerol (2‐AG) [β = 0.32 (SE = 0.15)] were associated with withdrawal symptoms in women only. Pharmacotherapeutic development for CUD should consider evident sex differences in eCB and eCB congener tone during abstinence and their associations with cannabis withdrawal, as eCB‐based interventions may produce differential effects by sex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabisMarijuana AbuseSubstance-Related DisordersSubstance Withdrawal SyndromeAdultFemaleHumansMaleEndocannabinoidsPilot ProjectsSex CharacteristicsCannabinoid Receptor Agonists

Stichwörter der Autor:innen

cannabis use disorderendocannabinoidsex differenceswithdrawal

Substanzen

EndocannabinoidsCannabinoid Receptor Agonists

Autor:innen und Institutionen

  • Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
  • iC42 Clinical Research and Development, Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Institute of Cognitive Science, University of Colorado Boulder, Boulder, Colorado, USA.
  • Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
  • Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.

ORCID-Profile: Erin L Martin, Nathaniel L Baker

Förderung

  • NIDA NIH HHS
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institute on Drug Abuse
  • Medical University of South Carolina

Zitieren

APA

Martin, E. L., Baker, N. L., Sempio, C., Christians, U., Klawitter, J., & McRae-Clark, A. L. (2023). Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence. Addiction Biology. https://doi.org/10.1111/adb.13337

Vancouver

Martin EL, Baker NL, Sempio C, Christians U, Klawitter J, McRae-Clark AL. Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence. Addiction Biology. 2023. doi:10.1111/adb.13337

BibTeX
@article{Martin2023,
  author = {Martin, Erin L and Baker, Nathaniel L and Sempio, Cristina and Christians, Uwe and Klawitter, Jost and McRae-Clark, Aimee L},
  title = {Sex differences in endocannabinoid tone in a pilot study of cannabis use disorder and acute cannabis abstinence},
  journal = {Addiction Biology},
  year = {2023},
  doi = {10.1111/adb.13337}
}
Kostenlos starten →